2022年11月23日

Share Arterys是世界上第一个医学成像互联网平台的开发商，现在是Tempus的一部分，宣布其产品和合作伙伴关系的有机增长，为放射科医生提供更快，更准确的诊断工具。Arterys首席执行官John axerio - ciles表示:“Arterys正处于关键时刻，我们在扩展解决方案方面具有独特的优势。“我们很高兴引入新的合作伙伴关系和产品更新，这将支持医生提供个性化的、数据驱动的患者护理。”Arterys的乳腺人工智能产品迅速扩张，最近有几家新客户采用了基于云的解决方案，还有更多客户承诺到2023年。在堪萨斯州的萨利纳，Arterys乳房人工智能的SaaS模式使该网站能够在运营预算下实施先进的技术。在佛罗里达州，一家全国性的乳腺公司对乳房分类工作表与CAD病例评分结果的结合感到非常兴奋，这有助于指导患者立即进行高级诊断成像——他们将在明年将该解决方案扩展到全国的多个站点。蒙大拿州的第三家站点发现Arterys对多个龙门架供应商是不可知的，云解决方案可以添加到新的龙门架上，也可以部署到没有资本设备的旧龙门架上。intervision - Arterys和intervision合作提供优化的人工智能驱动的肺肿瘤工作流程，包括fda批准的检测、分割和随访。使用合作伙伴的自动选择结节类型和自动lung -rad评分和RECIST提高了报告效率。DeepLook Medical - Arterys和DeepLook Medical联手为医生提高效率，消除肿瘤工作流程中的主观性。DeepLook的fda批准的DL Precise™自动分割工具已添加到Arterys放射学平台。 Precise measurements are crucial to accurately characterize tumors for cancer treatment plans, as well as to assess the tumor’s growth rate over time or tumor shrinkage in response to therapy. This partnership created a one-click tool to automate the segmentation and measurement of suspicious objects in all imaging modalities, moving one step closer to delivering on a vision of precision medicine and personalized patient care. Amazon Web Services (AWS) — Arterys is working with AWS to launch Amazon HealthLake Imaging, a new HIPAA-eligible capability for storing, sharing, and analyzing medical images at petabyte scale, now available in preview. As an AWS Partner, Arterys is leveraging HealthLake Imaging to enhance performance and responsiveness across its applications, such as Lung AI, which helps physicians analyze and track lung nodules by automatically processing Lung CT scans which delivers improved speed, efficiency, and accuracy of diagnostic decisions. Arterys will demonstrate the use of HealthLake Imaging in the AWS booth (#6958) during RSNA. HealthLake Imaging enables access to medical imaging data with sub-second image retrieval latencies at scale powered by cloud-native APIs and applications from AWS Partners. Providers can realize the cost savings of transitioning to the cloud while preserving low latency performance, eliminating the burden of infrastructure management, and enabling AI/ML to drive increased value from imaging data with support from other services. This allows providers to focus resources on meeting the growing demands of clinical workflows and delivering high-quality patient care. Arterys has been recently acquired by Tempus, a technology company advancing precision medicine through the practical application of AI. Launched in 2015, the company’s platform helps enable physicians to make near real-time, data-driven decisions to deliver personalized patient care and, in parallel, facilitates discovery, development, and delivery of optimal therapeutics to enable doctors to make data-driven treatment decisions, drug companies to make better drugs, and patients to live longer and healthier lives. Together, the two companies aim to better support physicians by providing the AI-enabled solutions necessary to optimize care.